[Clinical features and immunotherapy for children with loss-of-function/gain-of-function mutations in the <i>STAT</i> gene: an analysis of 10 cases]. [PDF]
Li HW +8 more
europepmc +1 more source
[A risk prediction model for prognosis and immunotherapy response in prostate cancer patients based on immunosuppressive neutrophil Neu_2 subsets]. [PDF]
Chen Z +5 more
europepmc +1 more source
[Case Report and Literature Review of Severe Anemia Secondary to Chemotherapy Combined with PD-1 Monoclonal Antibody Immunotherapy for Lung Adenocarcinoma]. [PDF]
Hu Y, Zhao J, Gao X, Xu Y, Wang M.
europepmc +1 more source
[FCN3 Can Serve as A Potential Biomarker for Prognosis and Immunotherapy of Lung Squamous Cell Carcinoma]. [PDF]
Li W, Zu L, Xu S.
europepmc +1 more source
[Case Report: Histological Transformation to Atypical Carcinoid in RET Fusion-positive NSCLC Following Immune Therapy Resistance]. [PDF]
Zhang Y +4 more
europepmc +1 more source
[Analysis of Efficacy and Safety of Neoadjuvant Immunochemotherapy in Patients with Stage IB-IIIB Non-small Cell Lung Cancer]. [PDF]
Li Z +7 more
europepmc +1 more source
[A pan-cancer analysis of PYCR1 and its predictive value for chemotherapy and immunotherapy responses in bladder cancer]. [PDF]
Li Y, Song X, Sun R, Dong X, Liu H.
europepmc +1 more source
Nano-Bacillus Calmette-Guérin immunotherapies for improved bladder cancer treatment. [PDF]
Zeng S, Xing S, Zhang Y, Wang H, Liu Q.
europepmc +1 more source
[Immunotherapy for Extensive-stage Small Cell Lung Cancer: Research Progress and Future Perspectives]. [PDF]
Zhong Y, Wang J, Wu L.
europepmc +1 more source
[Advancements in Radiomics for Immunotherapy of Non-small Cell Lung Cancer]. [PDF]
Hou Y, Zhang T, Wang H.
europepmc +1 more source

